|
Rajshahi City
mdr-tb patients ![]() Mdr Tb Patients, supplied by Rajshahi City, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mdr-tb patients/product/Rajshahi City Average 90 stars, based on 1 article reviews
mdr-tb patients - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Guiyang Xintian Pharmaceutical Co Ltd
spatial–temporal cluster map of mdr-tb cases ![]() Spatial–Temporal Cluster Map Of Mdr Tb Cases, supplied by Guiyang Xintian Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/spatial–temporal cluster map of mdr-tb cases/product/Guiyang Xintian Pharmaceutical Co Ltd Average 90 stars, based on 1 article reviews
spatial–temporal cluster map of mdr-tb cases - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Genetix Biotech
smart sure™ mtb multidrug-resistant-tb (mdr-tb) kits ![]() Smart Sure™ Mtb Multidrug Resistant Tb (Mdr Tb) Kits, supplied by Genetix Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/smart sure™ mtb multidrug-resistant-tb (mdr-tb) kits/product/Genetix Biotech Average 90 stars, based on 1 article reviews
smart sure™ mtb multidrug-resistant-tb (mdr-tb) kits - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Seegene Technologies
anyplextm plus mtb/ntm/dr-tb ![]() Anyplextm Plus Mtb/Ntm/Dr Tb, supplied by Seegene Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anyplextm plus mtb/ntm/dr-tb/product/Seegene Technologies Average 90 stars, based on 1 article reviews
anyplextm plus mtb/ntm/dr-tb - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
New Brunswick Scientific
methicillin-sensitive s. aureus (mssa) isolates mpw001 and mpw004 ![]() Methicillin Sensitive S. Aureus (Mssa) Isolates Mpw001 And Mpw004, supplied by New Brunswick Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/methicillin-sensitive s. aureus (mssa) isolates mpw001 and mpw004/product/New Brunswick Scientific Average 90 stars, based on 1 article reviews
methicillin-sensitive s. aureus (mssa) isolates mpw001 and mpw004 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Seegene Technologies
anyplex plus mdr-tb detection ![]() Anyplex Plus Mdr Tb Detection, supplied by Seegene Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anyplex plus mdr-tb detection/product/Seegene Technologies Average 90 stars, based on 1 article reviews
anyplex plus mdr-tb detection - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
max mdr-tb assay ![]() Max Mdr Tb Assay, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/max mdr-tb assay/product/Becton Dickinson Average 90 stars, based on 1 article reviews
max mdr-tb assay - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
max mdr-tb ![]() Max Mdr Tb, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/max mdr-tb/product/Becton Dickinson Average 90 stars, based on 1 article reviews
max mdr-tb - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Guiyang Xintian Pharmaceutical Co Ltd
mdr-tb diagnosis and treatment ![]() Mdr Tb Diagnosis And Treatment, supplied by Guiyang Xintian Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mdr-tb diagnosis and treatment/product/Guiyang Xintian Pharmaceutical Co Ltd Average 90 stars, based on 1 article reviews
mdr-tb diagnosis and treatment - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Guiyang Xintian Pharmaceutical Co Ltd
mdr-tb burden ![]() Mdr Tb Burden, supplied by Guiyang Xintian Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mdr-tb burden/product/Guiyang Xintian Pharmaceutical Co Ltd Average 90 stars, based on 1 article reviews
mdr-tb burden - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
National Reference Center for Legionella
mdr-tb dnas ![]() Mdr Tb Dnas, supplied by National Reference Center for Legionella, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mdr-tb dnas/product/National Reference Center for Legionella Average 90 stars, based on 1 article reviews
mdr-tb dnas - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Raipur Municipal
rsby and msby mdr-tb packages ![]() Rsby And Msby Mdr Tb Packages, supplied by Raipur Municipal, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/rsby and msby mdr-tb packages/product/Raipur Municipal Average 90 stars, based on 1 article reviews
rsby and msby mdr-tb packages - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: PLoS ONE
Article Title: Performance of GenoType MTBDR sl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh
doi: 10.1371/journal.pone.0261329
Figure Lengend Snippet: Demographic and clinical characteristics of 218 MDR-TB patients.
Article Snippet: The majority (85.8%) of the
Techniques:
Journal: BMC Infectious Diseases
Article Title: Time trend prediction and spatial–temporal analysis of multidrug-resistant tuberculosis in Guizhou Province, China, during 2014–2020
doi: 10.1186/s12879-022-07499-9
Figure Lengend Snippet: The SI of MDR-TB cases distribution in each month from 2014 to 2020 in Guizhou Province
Article Snippet: One most likely cluster and two secondary clusters were shown in Fig. . Fig. 7 The detected spatial–temporal cluster map of
Techniques:
Journal: BMC Infectious Diseases
Article Title: Time trend prediction and spatial–temporal analysis of multidrug-resistant tuberculosis in Guizhou Province, China, during 2014–2020
doi: 10.1186/s12879-022-07499-9
Figure Lengend Snippet: Comparison of actual and predicted cases of MDR-TB in Guizhou China. the black and green lines represent the observed values and predicted values, respectively; blue line represents 95% confidence intervals; after grey vertical line, the orange and yellow part represent 80% and 95% confidence intervals, respectively
Article Snippet: One most likely cluster and two secondary clusters were shown in Fig. . Fig. 7 The detected spatial–temporal cluster map of
Techniques: Comparison
Journal: BMC Infectious Diseases
Article Title: Time trend prediction and spatial–temporal analysis of multidrug-resistant tuberculosis in Guizhou Province, China, during 2014–2020
doi: 10.1186/s12879-022-07499-9
Figure Lengend Snippet: The geographical distribution of total MDR-TB cases in Guizhou from 2014 to 2020. a The geographical location of Guizhou in China; b The geographical location of 9 prefectures in Guizhou; c The geographical location of 88 counties in 9 prefectures, and distribution of total MDR-TB cases over seven years in each county
Article Snippet: One most likely cluster and two secondary clusters were shown in Fig. . Fig. 7 The detected spatial–temporal cluster map of
Techniques:
Journal: BMC Infectious Diseases
Article Title: Time trend prediction and spatial–temporal analysis of multidrug-resistant tuberculosis in Guizhou Province, China, during 2014–2020
doi: 10.1186/s12879-022-07499-9
Figure Lengend Snippet: Maps of local spatial autocorrelation cluster of MDR-TB for each county in Guizhou province from 2014 to 2020 by ArcMap software. Only those counties whose local Moran’s I have reached the significance level of 0.05 will be present on the map: a MDR-TB clusters in 2014; b MDR-TB clusters in 2015; c MDR-TB clusters in 2016; d MDR-TB clusters in 2017; e MDR-TB clusters in 2018; f MDR-TB clusters in 2019; g MDR-TB clusters in 2020
Article Snippet: One most likely cluster and two secondary clusters were shown in Fig. . Fig. 7 The detected spatial–temporal cluster map of
Techniques: Software
Journal: BMC Infectious Diseases
Article Title: Time trend prediction and spatial–temporal analysis of multidrug-resistant tuberculosis in Guizhou Province, China, during 2014–2020
doi: 10.1186/s12879-022-07499-9
Figure Lengend Snippet: The detected spatial–temporal cluster map of MDR-TB cases in Guizhou (2014–2020)
Article Snippet: One most likely cluster and two secondary clusters were shown in Fig. . Fig. 7 The detected spatial–temporal cluster map of
Techniques:
Journal: BMC Infectious Diseases
Article Title: Time trend prediction and spatial–temporal analysis of multidrug-resistant tuberculosis in Guizhou Province, China, during 2014–2020
doi: 10.1186/s12879-022-07499-9
Figure Lengend Snippet: Demographic characteristics of MDR-TB cases in Guizhou Province, 2014–2020 (n, %)
Article Snippet: One most likely cluster and two secondary clusters were shown in Fig. . Fig. 7 The detected spatial–temporal cluster map of
Techniques:
Journal: BMC Infectious Diseases
Article Title: Time trend prediction and spatial–temporal analysis of multidrug-resistant tuberculosis in Guizhou Province, China, during 2014–2020
doi: 10.1186/s12879-022-07499-9
Figure Lengend Snippet: The geographical distribution of MDR-TB cases in Guizhou Province, 2014–2020
Article Snippet: One most likely cluster and two secondary clusters were shown in Fig. . Fig. 7 The detected spatial–temporal cluster map of
Techniques:
Journal: BMC Infectious Diseases
Article Title: Time trend prediction and spatial–temporal analysis of multidrug-resistant tuberculosis in Guizhou Province, China, during 2014–2020
doi: 10.1186/s12879-022-07499-9
Figure Lengend Snippet: Spatial − temporal scan of MDR-TB in Guizhou from 2014 to 2020
Article Snippet: One most likely cluster and two secondary clusters were shown in Fig. . Fig. 7 The detected spatial–temporal cluster map of
Techniques:
Journal: BMC Infectious Diseases
Article Title: Time trend prediction and spatial–temporal analysis of multidrug-resistant tuberculosis in Guizhou Province, China, during 2014–2020
doi: 10.1186/s12879-022-07499-9
Figure Lengend Snippet: The geographical distribution of MDR-TB cases in Guizhou Province, 2014–2020
Article Snippet: The descriptive analysis gave a rough impression that 4 prefectures (Bijie,
Techniques:
Journal: Health Economics Review
Article Title: Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
doi: 10.1186/s13561-018-0187-5
Figure Lengend Snippet: Universal Health Insurance Scheme (UHIS) as managed by RSBY and MSBY (Developed from Cotlear et al. , 2015)
Article Snippet: Primary claims data on the uptake of
Techniques:
Journal: Health Economics Review
Article Title: Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
doi: 10.1186/s13561-018-0187-5
Figure Lengend Snippet: RSBY and MSBY, a business model, an organization as a nexus of contracts/ institutions (Developed from Kutzin J. Health financing for universal coverage and health system performance: concepts and implications for policy, Bulletin of World Health Organization, 2013;91(8): 602–11; and concept of organization as a nexus of contracts by Bruno Messen, Institute of Tropical Medicine, Antwerp. 2016)
Article Snippet: Primary claims data on the uptake of
Techniques:
Journal: Health Economics Review
Article Title: Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
doi: 10.1186/s13561-018-0187-5
Figure Lengend Snippet: Key characteristics of the beneficiaries of all MDR-TB Packages (2013–2015)
Article Snippet: Primary claims data on the uptake of
Techniques:
Journal: Health Economics Review
Article Title: Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
doi: 10.1186/s13561-018-0187-5
Figure Lengend Snippet: Pooled (RSBY and MSBY) MDR-TB hospital stay package utilization in the public and private sector from 2013 to 2015
Article Snippet: Primary claims data on the uptake of
Techniques:
Journal: Health Economics Review
Article Title: Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
doi: 10.1186/s13561-018-0187-5
Figure Lengend Snippet: Pooled (RSBY and MSBY) MDR-TB follow-up package utilization in the public and private sector from 2013 to 2015
Article Snippet: Primary claims data on the uptake of
Techniques:
Journal: Health Economics Review
Article Title: Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
doi: 10.1186/s13561-018-0187-5
Figure Lengend Snippet: Disaggregated pooled (RSBY and MSBY) data on claims utilization of MDR-TB pre-treatment evaluation package by poor in the public sector from 2013 to 2015
Article Snippet: Primary claims data on the uptake of
Techniques:
Journal: Health Economics Review
Article Title: Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India
doi: 10.1186/s13561-018-0187-5
Figure Lengend Snippet: Disaggregated pooled (RSBY and MSBY) data on claims utilization of MDR-TB pre-treatment evaluation package by non-poor in the private sector from 2013 to 2015
Article Snippet: Primary claims data on the uptake of
Techniques: